BIRAC is supporting Early Translation Accelerators (ETAs) to focus on catalyzing transformation of young academic discoveries (publications/patents) with possible commercially viable ventures and technologies. The aim of ETA is to add translational component to establish proof-of-concept/ Validation and to attract industry to take these validated technologies further in terms of development and is expected to collaborate with academic investigators, engage industry and to leverage international translation ecosystems. Two ETA have been already established at C-CAMP and IIT-Madras Bioincubator.
Bio incubators, National Research Laboratories, Government funded Laboratories and National Institutes with demonstrated experience in performing translational activities in the proposed area can apply for this proposal.
The critical components of ETA include continuous flow of discoveries, with potential applications, from academic investigators; a scientific component that evaluates, collaborates, and provides technology access to the discovery projects; and early engagement with industry and investors to help drive the discoveries and validated technologies towards successful commercialization through mentoring, partnerships and technology transfer.
Discoveries from Healthcare, agriculture, industrial biotechnology and other important areas of Biotechnology may be considered for validation under early translation accelerator. The criteria for selection, assessment of progress and graduation may be put in place by individual ETAs and the committees with experts from academia, industry, investors and IP/regulatory fields to ensure the discoveries are ready to be taken up by ETA and the discoveries considered under ETA are industry ready once developed and they are expected to be part of development cycle, along with the inventor or originator of such scouted technology.
